脳
鏀惰棌-鍋ュ悍緗戜細鍛樿闂褰?/h3>
| 緗戦〉鏍囬錛? | |
脳
娉ㄥ唽鍋ュ悍緗戠敤鎴?/h3>
| 鐢?鎴?鍚嶏細 | ||
|---|---|---|
| 鑱?緋?浜猴細 | 鎬?nbsp; 鍒細 | |
| 瀵?nbsp; 鐮侊細 | ||
| 閲嶅瀵嗙爜錛?/th> | ||
| 鐢靛瓙閭錛?/th> | ||
| 閭楠岃瘉鐮侊細 | ||
| 鍥哄畾鐢佃瘽錛?/th> | ||
| 浼?nbsp; 鐪燂細 | ||
| 鎵?nbsp; 鏈猴細 | ||
| 鍗曚綅鍚嶇О錛?/th> | ||
| 閫氫俊鍦板潃錛?/th> | ||
| 棣栭夋爮鐩細 | ||
| 鎴戝凡緇忚鐪熼槄璇誨茍鍚屾剰銆婂仴搴風綉鏈嶅姟鏉℃銆?/a> | ||
| 紜畾娉ㄥ唽 | ||
鎮ㄧ幇鍦ㄤ綅緗細鍋ュ悍緗?鍖昏嵂浜т笟 >> 縐戠爺淇℃伅 >> 鏂拌嵂鍔ㄦ?/a> >> 鏂拌嵂榪涘睍 >> 嫻忚縐戠爺淇℃伅
涓嬩笜鑴戞ц偉鑳栬嵂鐗╄幏FDA鎺堜簣紿佺牬鎬х枟娉曡瀹?/H1>
浣滆咃細yuanxc 鏉ユ簮錛氬叾瀹?nbsp; 鐐瑰嚮鏁幫細0 鏇存柊鏃墮棿錛?022-11-3 15:37:07
鐩稿叧榪炴帴
FDA Success Stories CDE Recommendations: How MIDD Accelerates Drug Discovery?
The worlds first Upadatinib extended-release tablets approved by FDA for non-radiological axial spondyloarthritis
鎭掔憺鍖昏嵂鑱斿悎鐤楁硶鎷熺撼鍏ョ獊鐮存ф不鐤楀搧縐?/a>
FDA 榪炲彂涓変喚鐧岀棁娌葷枟鑽紑鍙戠浉鍏蟲寚鍗?/a>
Sodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapySodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapy
FDA 灝卞浣曞湪鐢蟲姤璧勬枡涓彁浜ょ湡瀹炰笘鐣屾暟鎹拰璇佹嵁鍙戝竷瀹氱ǹ鎸囧崡
FDA鍐嶃屽彉鑴搞嶏紝鑽紒濡備綍鍦ㄧ煕鐩句腑瀹夎韓绔嬪懡
FDA approves ibrutinib for chronic graft-versus-host disease in children 1 year older
The worlds first Upadatinib extended-release tablets approved by FDA for non-radiological axial spondyloarthritis
鎭掔憺鍖昏嵂鑱斿悎鐤楁硶鎷熺撼鍏ョ獊鐮存ф不鐤楀搧縐?/a>
FDA 榪炲彂涓変喚鐧岀棁娌葷枟鑽紑鍙戠浉鍏蟲寚鍗?/a>
Sodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapySodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapy
FDA 灝卞浣曞湪鐢蟲姤璧勬枡涓彁浜ょ湡瀹炰笘鐣屾暟鎹拰璇佹嵁鍙戝竷瀹氱ǹ鎸囧崡
FDA鍐嶃屽彉鑴搞嶏紝鑽紒濡備綍鍦ㄧ煕鐩句腑瀹夎韓绔嬪懡
FDA approves ibrutinib for chronic graft-versus-host disease in children 1 year older